Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Sep 28, 2019; 25(36): 5515-5529
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5515
Table 3 Performance of protein induced by vitamin K absence or antagonist II, alpha-fetoprotein, and the ratio of gamma-glutamyltransferase and aspartate aminotransferase in hepatitis B virus DNA+ and hepatitis B virus DNA- hepatocellular carcinoma patients
HBV DNA+ HCC
HBV DNA- HCC
Cut-offSEN (%)SPE (%)PPV (%)NPV (%)Cut-offSEN (%)SPE (%)PPV (%)NPV (%)
PIVKA-II (mAu/mL)84.4492.0092.6080.9297.14154.9272.7091.1087.6879.30
AFP (ng/mL)497.7058.0088.8063.8586.11146.1558.0097.0094.4072.61
γ-GT/AST0.64088.6060.5043.3493.960.83085.2052.5060.9880.28
PIVKA-II + AFPNA89.8092.2079.7096.36NA80.7087.1084.5083.82
PIVKA-II + γ-GT/ASTNA89.8092.6080.5496.38NA79.5078.2076.0681.41
AFP + γ-GT/ASTNA70.5089.1068.8189.85NA75.0078.2074.9878.21
PIVKA-II + AFP + γ-GT/ASTNA90.9092.2079.9096.74NA79.5086.1083.2982.82